Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer

The effect on the IGF system of 60 mg and 600 mg daily of raloxifene administered for 2 weeks prior to surgery was investigated in 37 postmenopausal women with breast cancer. Raloxifene significantly decreased insulin-like growth factor (IGF-I) as compared to placebo (P < 0.05) with no dose–respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrisi, R, Baglietto, L, Johansson, H, Veronesi, G, Bonanni, B, Guerrieri-Gonzaga, A, Ballardini, B, Decensi, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364027/
https://www.ncbi.nlm.nih.gov/pubmed/11747323
http://dx.doi.org/10.1054/bjoc.2001.2191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364027/
https://www.ncbi.nlm.nih.gov/pubmed/11747323
http://dx.doi.org/10.1054/bjoc.2001.2191

Ejemplares similares